Feedback / Questions
Jemperli (dostarlimab-gxly) - GSK
belrestotug (EOS-448) - iTeos, GSK
https://medicaldialogues.in/news/industry/pharma/cdsco-panel-approves-gsk-protocol-amendment-proposal-for-belrestotug-and-dostarlimab-study-140572
Dec 27, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next